Piper Sandler Keeps an Overweight Rating on ImmunityBio, Inc. (IBRX)

Piper Sandler Keeps an Overweight Rating on ImmunityBio, Inc. (IBRX)

📰 Original Source

Read full article at Finance →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.